Table 3.
Risk of Stomach Malignancies in People With AIDS in the United States Compared With the General Population
| Tumor histology/anatomy | Σ observed | SIR (95% CI) |
|---|---|---|
| Carcinomas by histology | ||
| Total carcinoma | 96 | 1.44 (1.17–1.76) |
| Adenocarcinoma total | 89 | 1.40 (1.12–1.72) |
| Adenocarcinoma, diffuse | 26 | 1.65 (1.08–2.41) |
| Adenocarcinoma, intestinal | 10 | 1.96 (0.94–3.61) |
| Unspecified adenocarcinomas | 53 | 1.24 (0.93–1.62) |
| Other/unspecified carcinomas | 7 | 2.33 (0.94–4.80) |
| Carcinomas by anatomic site | ||
| Cardia | 20 | 1.36 (0.83–2.11) |
| Total noncardia | 46 | 1.53 (1.12–2.05) |
| Fundus/body noncardia | 7 | 0.96 (0.39–1.98) |
| Antrum/pylorus noncardia | 32 | 2.30 (1.57–3.25) |
| Unspecified noncardia site | 7 | 0.80 (0.32–1.64) |
| Unspecified site | 30 | 1.37 (0.92–1.95) |
| NHLs by histology | ||
| Total NHL | 348 | 35.5 (31.9–39.5) |
| Diffuse large B-cell | 228 | 48.8 (42.7–55.6) |
| Burkitt | 16 | 54.5 (31.1–88.4) |
| MALT | 13 | 5.99 (3.19–10.2) |
| Other/unspecified NHLs | 91 | 34.2 (27.5–42.0) |